COMPOUND TRANSFER AND DEVELOPMENT AGREEMENTCompound Transfer and Development Agreement • March 17th, 2008 • Gene Logic Inc • In vitro & in vivo diagnostic substances • Delaware
This COMPOUND TRANSFER AND DEVELOPMENT AGREEMENT (the “Agreement”) is entered into and effective as of July 26, 2006 (the “Effective Date”), by and between Gene Logic Inc. (“GLGC”), a Delaware corporation with a principal address at 610 Professional Drive, Gaithersburg, MD 20879, and Millennium Pharmaceuticals, Inc., (“MLNM”), a Delaware corporation with a principal address at 40 Landsdowne Street, Cambridge, MA 02139 (each a “Party” and collectively, the “Parties” to this Agreement).
